ArticleTherapeutic innovation & regulatory science2026

Present and Future Post-marketing Drug Safety Assessment in Japan: A PMDA Perspective.

Takashi Waki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.